Press Releases April 29, 2026 10:21 AM

Bath & Body Works Appoints Veronique Gabai-Pinsky as Chief Brand & Product Officer

Bath & Body Works appoints Veronique Gabai-Pinsky as first Chief Brand & Product Officer to drive brand innovation and growth

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
BBWI

Bath & Body Works announced the appointment of Veronique Gabai-Pinsky as its first-ever Chief Brand & Product Officer. Gabai-Pinsky, with over three decades of experience in beauty, fragrance, fashion, and luxury sectors, will lead the company's brand and product strategies to elevate consumer offerings, accelerate innovation, and reignite the brand. She will join the Executive Leadership Team and report to the CEO, reinforcing the company's transformation and growth initiatives.

Bath & Body Works Appoints Veronique Gabai-Pinsky as Chief Brand & Product Officer
BBWI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Veronique Gabai-Pinsky appointed as Chief Brand & Product Officer, bringing extensive experience from Estee Lauder, Vera Wang Group, and luxury beauty sectors.
  • Bath & Body Works aims to modernize its consumer offering, enhance fragrance leadership, and accelerate product innovation under her leadership.
  • The company is focusing on connecting authentically with consumers through creativity, storytelling, and meaningful brand experiences.
  • Impacted sectors include consumer discretionary, specifically the beauty, personal care, and fragrance markets.

COLUMBUS, Ohio, April 29, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) today announced the appointment of Veronique Gabai-Pinsky as its first-ever chief brand & product officer, effective May 18, 2026, building on her contributions as a creative product & brand adviser to the company.   

As chief brand & product officer, Gabai-Pinsky will lead the company’s brand and product organization further elevating Bath & Body Works’ consumer proposition, advancing its fragrance leadership, accelerating innovation, and reigniting the brand. She will join the Executive Leadership Team and report to Chief Executive Officer Daniel Heaf.  

“This is a critical role for Bath & Body Works as we continue to transform the business, modernize our consumer offering and return the brand to growth,” said Heaf. “Since joining us as an adviser, Veronique has already made an impact, bringing renewed creativity and a strong instinct for how to connect authentically with today’s consumers. As our first chief brand & product officer, she brings a powerful combination of deep product experience, fragrance expertise, brand building and a track record of translating consumer insight into compelling products and brands. With her leadership, we are strengthening our ability to create innovative products, re-ignite our brand and meet the evolving expectations of today’s consumer.” 

Gabai-Pinsky brings three decades of experience across beauty, fragrance, fashion and luxury. Most recently, she founded her namesake brand, Veronique Gabai. Prior to that, she served as president of the Vera Wang Group, overseeing global operations, and spent 13 years at The Estée Lauder Companies, including her instrumental role as global president of the company’s fragrance division and independent skincare brands. Earlier in her career, she held leadership roles at Symrise, Guerlain and L’Oréal. Since November 2025, she has been serving as a creative product & brand adviser to Bath & Body Works, partnering with teams to elevate the brand and product experience.

“Consumers today are looking for more from the brands they love: greater efficacy, more intentional craftsmanship, more meaningful experiences, a value system they can share and a community they are proud to belong to,” said Gabai-Pinsky. “Bath & Body Works has a unique ability to connect product, emotion and everyday feel-good rituals in a way very few brands can. Having seen firsthand the strength of the team and the opportunity ahead, I’m excited and honored to build on that momentum by elevating product innovation, deepening our storytelling and connection with consumers, and creating even more inspiring experiences that resonate with today’s consumer.” 

ABOUT BATH & BODY WORKS  

Bath & Body Works is a global leader in personal care and home fragrance, driven by the belief that everybody deserves to feel good. The brand’s beloved and iconic scents are expertly crafted for exceptional performance and a luxury fragrance experience. Formulated with thoughtfully chosen ingredients, Bath & Body Works’ body care products are available in multiple forms including fine fragrance mist, body cream, lotion, eau de parfum, body wash, hand soap, sanitizer and more. The brand’s famous 3-wick candles are made with rich, high quality fragrance oils layered throughout a premium soy wax base, for up to 45 hours of room-filling fragrance. Consumers can shop Bath & Body Works anytime and anywhere they choose, from welcoming, in-store experiences at more than 1,900 stores in the U.S. and Canada, 500-plus international locations, online at bathandbodyworks.com and on Amazon.  

MEDIA CONTACT:
Emmy Beach
Communications@bbw.com


Risks

  • Execution risk in successfully transforming and modernizing the brand to meet evolving consumer preferences.
  • Competitive pressures within the beauty and personal care market, which could impact growth and innovation effectiveness.
  • Economic factors affecting consumer discretionary spending could influence Bath & Body Works' sales performance.

More from Press Releases

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026